Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial
Mosunetuzumab 与 polatuzumab vedotin 联合治疗复发或难治性侵袭性大 B 细胞淋巴瘤：一项 1b/2 期临床试验
期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-023-02726-5
Lihua E Budde, Adam J Olszewski, Sarit Assouline, Izidore S Lossos, Catherine Diefenbach, Manali Kamdar, Nilanjan Ghosh, Dipenkumar Modi, Waleed Sabry, Seema Naik, Amitkumar Mehta, Shazia K Nakhoda, Stephen D Smith, Kathleen Dorritie, Ting Jia, Song Pham, Ling-Yuh Huw, Jing Jing, Hao Wu, Wahib S Ead
